Most oral diabetes medications including SGLT-2 inhibitors, GLP-1 receptor agonists, and DPP-4 inhibitors must be stopped before conception due to safety concerns
Tirzepatide and retatrutide, which have dual agonist activities targeting both GLP-1 receptor and GIP receptor (GIPR) or GLP-1 receptor and glucagon receptor (GCGR), respectively, have been shown to improve energy expenditure and metabolic flexibility in other studies [50, 51]
Honest framing : fat burners support, they don't replace, a calorie deficit + training + protein intake
We check thyroid function, insulin levels, inflammatory markers, and hormone balance to understand the full picture of your metabolic health
However, these proposed benefits are based on theory and limited research rather than established clinical evidence
Your body has never experienced pharmaceutical glucagon receptor agonism at these potencies